Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleotide synthesis is a complex metabolic process involving a set of biochemical reactions that produce nucleotides, which are fundamental building blocks of DNA and RNA. It encompasses both de novo synthesis (creating nucleotides from simple precursors) and salvage pathways (recycling existing nucleotide components). This process is energy-intensive and relies on numerous enzymes distributed throughout the cell. It is explicitly classified as a biochemical pathway or process, not a specific druggable molecular entity like a receptor, enzyme, or transporter. Therefore, it cannot be directly considered a therapeutic target. While its dysregulation is relevant to diseases like cancer, therapeutic interventions typically target specific enzymes within the pathway (e.g., ribonucleotide reductase, thymidylate synthase) rather than the entire synthesis process itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleotide Synthesis.